How many molecular subtypes? Implications of the unique tumor principle in personalized medicine - sprookjes - yvandenbroek - TriplyDB

How many molecular subtypes? Implications of the unique tumor principle in personalized medicine

How many molecular subtypes? Implications of the unique tumor principle in personalized medicine

http://www.wikidata.org/entity/Q26992045

about

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease Cancer classification in the genomic era: five contemporary problems Potential of epigenetic therapies in the management of solid tumors Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis research Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach Staphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach?Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma.Discretization of Gene Expression Data Unmasks Molecular Subgroups Recurring in Different Human Cancer Types Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management Challenges and opportunities in international molecular cancer prevention research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report.SMO expression in colorectal cancer: associations with clinical, pathological, and molecular features Proceedings of the second international molecular pathological epidemiology (MPE) meeting Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients.Structured decision-making: using personalized medicine to improve the value of cancer care.Lifecourse epidemiology and molecular pathological epidemiology.Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study Use of the comet assay technique for quick and reliable prediction of in vitro response to chemotherapeutics in breast and colon cancer.A Meta-Regression Method for Studying Etiological Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers.Personalized radiotherapy: concepts, biomarkers and trial design Systematic pan-cancer analysis of tumour purity.Accounting for tumor purity improves cancer subtype classification from DNA methylation data.Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.Integration of molecular pathology, epidemiology and social science for global precision medicine.Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level.Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors.Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer Tissue banking, bioinformatics, and electronic medical records: the front-end requirements for personalized medicine.

P2860

Q24289344-B2DEEB48-A6C6-4E3E-8E59-A215F03D53C1 Q26781783-72BFF6E2-3BD1-4779-9A8A-086990A7240E Q26783134-21DAB9CB-6D9F-42AA-95F4-B294318AB3E5 Q26796576-8DB4B07D-7055-43EC-AC3B-241600BB62D5 Q26827259-9F445161-B91E-41B9-8E65-2A8905C1FE68 Q26852716-350C5D55-A975-4AC4-B8FC-72DFA183DCB3 Q27011884-E7A22F22-7542-4237-9768-88B71D77B919 Q28277824-64639C2D-74B0-4AC7-A5F2-8E49BE9A5350 Q28284149-DDBC12DD-4447-40CB-B742-BCD8E6437A8C Q28647615-19DA860B-E384-47A4-817B-BBBC4CD4AAA1 Q30239977-FA74FB5A-5246-44D0-AC60-0278A5362D78 Q30244608-339FEE82-4CA5-4EA4-B2D6-A65A3E419385 Q30434521-46CCCBC5-B899-4AC3-978E-3B2A5456F114 Q31122277-7CB45697-0461-4A64-9C63-3ABC5C255E68 Q33565858-F92B5381-6D46-4345-9EC5-AA125CFBBBFC Q33940740-5194995F-D020-4007-B024-83687B3169E1 Q34016833-6D172E9E-F0F4-41F0-B00E-076AF2EE786B Q34034620-F1FC3CD1-CC4D-4892-8153-D66B8CBFCEE4 Q34441501-0D1E0A51-5EE9-4B19-AC29-2E58BD99D849 Q34458644-0CD832DC-20FC-4292-8B66-D6317F0F88C1 Q34475686-A8971F1C-DDB1-442A-AAEE-4AEE3DE5B8CE Q34502713-6D70776A-4EC7-4C3E-B3CE-79C8C9FE3A88 Q34517338-1BCF6F2F-896A-4AED-9437-52F9E2AE8FC8 Q34608684-2FC48A26-8813-4E11-B6A9-A2727E0E31F8 Q34762152-CEF336EA-C22F-4F4E-BE60-D4B299734626 Q35151053-23734B64-599E-4096-81E3-56A194878798 Q35317195-E7850837-1321-4AA0-8608-0C4D11389A38 Q35896952-BED84981-07D9-460C-8FE3-217A89E7E634 Q36235704-7B52949E-8B8B-4EE5-BF84-5E9648AE82DF Q36350773-5F2119B2-397F-4B3D-9806-0257260735D4 Q36363371-A723714E-603E-4487-9FEC-50E0E1ABAD50 Q36416491-B0469DC0-6F10-4B49-B3C4-0C0BA6770059 Q36463854-2529F8E4-4DD0-48AB-8675-3A1A071FD29C Q36535688-8557ECBE-503C-4957-96DA-5CE96995C228 Q36563705-AF4C9843-B8E6-490C-A172-641157E0B4A0 Q36651350-C865E395-9EA3-41EE-BF9D-1AAF99435B84 Q36675320-8329475C-1CA1-4114-93B4-2A6810368141 Q36761405-C66C2846-2EBD-4655-A8AE-42DC08BF8F96 Q36926941-60E50FD2-6C91-4046-94F3-216D63E92C6E Q36931470-B8C92C96-45F4-40DC-A2B1-EB998D5D9279

P2860

How many molecular subtypes? Implications of the unique tumor principle in personalized medicine

http://www.wikidata.org/entity/Q26992045

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

How many molecular subtypes? I ...... ciple in personalized medicine

@ast

How many molecular subtypes? I ...... ciple in personalized medicine

@en

How many molecular subtypes? I ...... ciple in personalized medicine

@nl

type

label

How many molecular subtypes? I ...... ciple in personalized medicine

@ast

How many molecular subtypes? I ...... ciple in personalized medicine

@en

How many molecular subtypes? I ...... ciple in personalized medicine

@nl

prefLabel

How many molecular subtypes? I ...... ciple in personalized medicine

@ast

How many molecular subtypes? I ...... ciple in personalized medicine

@en

How many molecular subtypes? I ...... ciple in personalized medicine

@nl

P1433

Q26992045-F7BDADB2-6C86-43F1-B5DB-19B6067ED4AB

P1476

Q26992045-51E8E0E6-CB6A-4BDA-B26E-6C09B5024965

P2093

Q26992045-4859E0FD-1062-47A9-82C9-F68E17BCF9C8

P2860

Q26992045-0165929A-7E67-4190-8A24-EA3A6A10B15B

Q26992045-09A95F7A-1117-4FBC-9A24-103E407C0A41

Q26992045-0DDFE4C2-1601-4400-B1E1-11C3B51BB0D8

Q26992045-0F40926F-89B3-476E-A4BD-B38FA62FA5CB

Q26992045-14537C47-EEA2-4971-B94E-F84C77B5ECEA

Q26992045-148A9BCC-548C-4B07-ADBA-AA80B9C82049

Q26992045-169C369C-E04C-44EA-8E4C-AA14C8BEB731

Q26992045-16F9820D-C0F4-4942-999F-A50B3F184056

Q26992045-1C05C837-2F24-4810-B419-60A75790ADB8

Q26992045-1F8E28DD-9DE9-4C6B-A810-D78905709117

P304

Q26992045-4D94D0E5-C76A-42E2-BF49-30435DBC7F88

P31

Q26992045-F096997A-FFE9-4FDB-9619-73E4EBB7C39A

P3181

Q26992045-6B252F92-E03D-451B-95DC-E35F52815053

P356

Q26992045-C3E7511E-548D-4199-BE70-01FB129152B3

P407

Q26992045-4EAF76CD-1D67-4C4F-AAE1-9F4973100FE9

P433

Q26992045-1B8B5F49-0D69-483D-A86F-3D49B1EDA23E

P478

Q26992045-58D8B470-C93E-4427-B599-E20B7D3FBA89

P50

Q26992045-C6A9611D-5789-4863-9B4F-78B4A33563B1

Q26992045-D932420E-C307-47EA-9749-FC606BC5470B

P577

Q26992045-3FA9C896-0E8E-4C0F-9F0D-B64C1D1DD154

P5875

Q26992045-306346F7-65E1-489E-B3F7-738A51185E48

P698

Q26992045-33367132-1D20-47E8-8DB2-81EB3DA00A09

P932

Q26992045-5D437856-9A0F-4C6A-AC43-B0AE955BC714

P3181

P356

P1433

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

P1476

How many molecular subtypes? I ...... ciple in personalized medicine

@en

P2093

Shuji Ogino

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer as an evolutionary and ecological process

Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review

Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science

Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

CpG island methylation in colorectal cancer: past, present and future

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

A decade of exploring the cancer epigenome - biological and translational implications

Molecular origins of cancer: Molecular basis of colorectal cancer

P304

621-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4024097

http://www.w3.org/2001/XMLSchema#string

P356

10.1586/ERM.12.46

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Edward Giovannucci

Charles S. Fuchs

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230587423

http://www.w3.org/2001/XMLSchema#string

P698

22845482

http://www.w3.org/2001/XMLSchema#string

P932

3492839

http://www.w3.org/2001/XMLSchema#string